Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct

Fig. 4

Expression of Sox2 and CD31 in the tumors of each treatment group. a The expression of Sox2 and CD31 were examined with WB assays. The quantification assay of WB results was also presented. Data shown was mean ± SD obtained from three independent experiments. * P < 0.05 vs Mock group, #P < 0.01 vs HM-3 + shScr-V group. b The representative images of IHC staining for Sox2 of tumors treated in each group. c The representative images of IHC staining for CD31 of tumors treated in each group

Back to article page